Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.90
+0.10 (1.28%)
Aug 24, 2026, 4:00 PM EDT - Market closed
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $819.27 million as of August 25, 2026. Its market cap has increased by 101.35% in one year.
Market Cap
819.27M
Enterprise Value
512.02M
1-Year Change
101.35%
Ranking
Category
Stock Price
$7.90
ChartMarket Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $819.27M, an increase of 105.98%. That is a compound annual growth rate of 16.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 819.27M | 136.72% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DBV Technologies | 862.94M |
| Obsidian Therapeutics | 862.19M |
| Rigel Pharmaceuticals | 857.22M |
| Pharming Group | 839.49M |
| Faeth Therapeutics | 826.89M |
| Achieve Life Sciences | 822.19M |
| Oculis Holding AG | 807.76M |
| Silence Therapeutics | 798.98M |